Neogen® To Participate in 2024 Wells Fargo Healthcare Conference


Werte in diesem Artikel
Aktien

8.09 EUR 0.02 EUR 0.25 %

LANSING, Mich., Aug. 29, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 5.

Neogen Corporation (PRNewsfoto/Neogen Corporation)

David Naemura, Neogen's Chief Financial Officer, will present at 3:00 PM Eastern Time.

To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Media Contact

Bill Waelke, Vice President, IR & Treasury
IR@Neogen.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-to-participate-in-2024-wells-fargo-healthcare-conference-302233467.html

SOURCE Neogen Corporation

Aktuelle Neogen Aktie News

Werbung

Neogen Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogen nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
31.03.11 Neogen neutral J.J.B. Hilliard, W.L. Lyons, Inc.
22.07.09 Neogen buy ROTH Capital Partners, LLC
20.03.09 Neogen buy ROTH Capital Partners, LLC
07.01.09 Neogen Kursziel gesenkt ROTH Capital Partners, LLC
26.09.08 Neogen neues Kursziel ROTH Capital Partners, LLC